CA2544373A1 - Blood test prototypes and methods for the detection of circulating tumor and endothelial cells - Google Patents

Blood test prototypes and methods for the detection of circulating tumor and endothelial cells Download PDF

Info

Publication number
CA2544373A1
CA2544373A1 CA002544373A CA2544373A CA2544373A1 CA 2544373 A1 CA2544373 A1 CA 2544373A1 CA 002544373 A CA002544373 A CA 002544373A CA 2544373 A CA2544373 A CA 2544373A CA 2544373 A1 CA2544373 A1 CA 2544373A1
Authority
CA
Canada
Prior art keywords
cells
cell
blood
cell adhesion
cam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002544373A
Other languages
English (en)
French (fr)
Inventor
Wen-Tien Chen
Lee Chen
Che Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitatex Inc
Original Assignee
Vitatex, Inc.
Wen-Tien Chen
Lee Chen
Che Chen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitatex, Inc., Wen-Tien Chen, Lee Chen, Che Chen filed Critical Vitatex, Inc.
Publication of CA2544373A1 publication Critical patent/CA2544373A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5082Test tubes per se
    • B01L3/50825Closing or opening means, corks, bungs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/04Cell isolation or sorting
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0081Purging biological preparations of unwanted cells
    • C12N5/0093Purging against cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/04Closures and closing means
    • B01L2300/046Function or devices integrated in the closure
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745Assays involving non-enzymic blood coagulation factors
    • G01N2333/75Fibrin; Fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Sustainable Development (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002544373A 2003-10-31 2004-10-30 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells Abandoned CA2544373A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51657103P 2003-10-31 2003-10-31
US60/516,571 2003-10-31
PCT/US2004/036177 WO2005043121A2 (en) 2003-10-31 2004-10-30 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells

Publications (1)

Publication Number Publication Date
CA2544373A1 true CA2544373A1 (en) 2005-05-12

Family

ID=34549552

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002544373A Abandoned CA2544373A1 (en) 2003-10-31 2004-10-30 Blood test prototypes and methods for the detection of circulating tumor and endothelial cells

Country Status (7)

Country Link
EP (1) EP1706720A4 (zh)
JP (1) JP2007526761A (zh)
CN (2) CN1922304A (zh)
AU (1) AU2004286307A1 (zh)
CA (1) CA2544373A1 (zh)
HK (1) HK1209778A1 (zh)
WO (1) WO2005043121A2 (zh)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913697B2 (en) 2001-02-14 2005-07-05 Science & Technology Corporation @ Unm Nanostructured separation and analysis devices for biological membranes
WO2004029221A2 (en) 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
US7910315B2 (en) 2004-09-10 2011-03-22 The Regents Of The University Of Colorado, A Body Corporate Early detection of hemangiosarcoma and angiosarcoma
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US7769547B2 (en) * 2005-11-01 2010-08-03 David S. Alberts Karyometry-based method for prediction of cancer event recurrence
CA2646497A1 (en) * 2006-04-18 2007-10-25 Wellstat Biologics Corporation Detection of circulating endothelial cells
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc HIGHLY PARALLEL SNP GENOTYPING UTILIZATION FOR FETAL DIAGNOSIS
EP1867995A1 (en) * 2006-06-15 2007-12-19 Cézanne S.A.S. In vitro method for diagnosing and monitoring metastasized bladder cancer using the determination of MMP-7 in the circulation of patients
MX2010004671A (es) * 2007-12-10 2010-05-27 Hoffmann La Roche Seprasa como marcador para cancer.
PT2562268T (pt) 2008-09-20 2017-03-29 Univ Leland Stanford Junior Diagnóstico não invasivo de aneuploidia fetal por sequenciação
ITCZ20090001A1 (it) * 2009-01-13 2010-07-14 Natalia Malara Isolamento e messa in coltura di cellule epiteliali tumorali dal sangue e dai suoi derivati in pazienti affetti da cancro epiteliale solido
EP2363501A1 (en) * 2010-03-02 2011-09-07 Universitätsklinikum Hamburg-Eppendorf Method for isolating target cells
CN102213722B (zh) * 2010-04-06 2014-03-12 北京蛋白质组研究中心 一种检测蛋白表达水平的试剂盒在制备诊断肝细胞癌的试剂盒中的应用
AU2011277178B2 (en) 2010-07-16 2016-10-20 Stichting Vumc A method of analysing a blood sample of a subject for the presence of a disease marker
CN103547920B (zh) 2011-03-18 2016-08-17 高等教育、科学研究及疾病护理协会 分析受试者的血液样品存在疾病标记物的方法
US9372136B2 (en) 2011-06-13 2016-06-21 Hitachi Chemical Company, Ltd. Agent for improving cancer cell adhesiveness
BR112014000329A2 (pt) * 2011-07-07 2017-02-07 Scripps Health método de análise de distúrbios cardiovasculares e uso do mesmo
JP6054389B2 (ja) * 2011-07-08 2016-12-27 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ 標識されたhsp90阻害剤の使用
JP5834559B2 (ja) * 2011-07-12 2015-12-24 コニカミノルタ株式会社 目的細胞の検査方法
JP6208473B2 (ja) 2012-06-20 2017-10-04 アークレイ株式会社 血液成分を含む試料の処理方法
WO2014072465A1 (en) * 2012-11-09 2014-05-15 Roche Diagnostics Gmbh In vitro capture and analysis of circulating tumor cells
EP2923191B1 (en) * 2012-11-20 2018-12-26 The Trustees of Columbia University in the City of New York Medical apparatus and method for collecting biological samples
GB2531881B (en) * 2013-02-02 2017-12-13 Univ Duke Method of isolating circulating tumor cells
CN106796237B (zh) * 2014-07-22 2018-12-04 株式会社癌症免疫研究所 末梢循环癌细胞的检测装置
KR102421024B1 (ko) * 2015-01-21 2022-07-14 에이전시 포 사이언스, 테크놀로지 앤드 리서치 크기에 기초한 희귀 세포의 회수를 위한 칼럼 기반 장치 및 방법, 및 이의 용도
JP6901253B2 (ja) * 2015-10-21 2021-07-14 株式会社日本触媒 接着性細胞培養用基材、ならびにこれを利用した細胞培養容器および細胞培養方法
CN105420088B (zh) * 2015-11-11 2017-12-29 深圳市达科为生物工程有限公司 一种细胞分离管
KR20170070839A (ko) * 2015-12-14 2017-06-22 주식회사 퀀타매트릭스 이종 세포들의 혼합물로부터 특정 세포를 구별하는 방법
JP6518985B2 (ja) * 2016-09-29 2019-05-29 住友ゴム工業株式会社 がん細胞捕捉方法
JP7118059B2 (ja) * 2016-11-02 2022-08-15 イー・エム・デイー・ミリポア・コーポレイシヨン 細胞培養液からマイクロキャリアを分離するための容器
CN110366597B (zh) * 2016-12-20 2024-03-29 善威生物私人有限公司 用蛋白酶抑制剂进行血液图谱分析
CN108220233B (zh) * 2016-12-21 2021-07-09 上海透景诊断科技有限公司 细胞分离器具表面处理方法、相关器具、外周血稀有细胞或循环肿瘤细胞快速高效分离方法
EP3342485B1 (de) * 2017-01-02 2020-07-08 Thinxxs Microtechnology Ag Halterung für reagenzträgerelemente
CN106754650B (zh) * 2017-02-24 2018-10-02 哈尔滨中科赛恩斯生物技术有限公司 一种骨髓来源的内皮祖细胞培养方法
CN106840816A (zh) * 2017-03-14 2017-06-13 骏实生物科技(上海)有限公司 一种全自动循环肿瘤细胞阴性富集装置
EP3596467B1 (en) * 2017-03-16 2023-09-27 Université Libre de Bruxelles Detection, quantification and/or isolation of circulating tumor cells based on the expression of cd321 marker
WO2019023961A1 (en) * 2017-08-02 2019-02-07 Suzhou Bofu Biomedical Limited METHOD OF CAPTURING TARGET CELLS OR MOLECULES IN SOLUTION
US20200156073A1 (en) * 2017-08-02 2020-05-21 Hemosmart Medical Technology Ltd. Functionalized mesh and fluidic apparatus for capturing cells or molecules in solution
CN108031614B (zh) * 2017-12-14 2020-04-17 四川福德机器人股份有限公司 一种燃气表的涂胶自动补偿方法及采用该方法的装置
WO2019185874A1 (en) * 2018-03-30 2019-10-03 Exosomics S.p.A. Use of hollow fibers to obtain blood or a blood derivative impoverished from blood cells and platelets derived extracellular vesicles
CN109294973A (zh) * 2018-10-18 2019-02-01 重庆医科大学 一种基于磁珠法阴性去除血尿白细胞富集上皮细胞的方法
CN109887542A (zh) * 2019-02-12 2019-06-14 嘉兴海云惠智医疗科技有限公司 一种基于云计算的肿瘤个体化基因检测智能解读系统
CN111751543A (zh) * 2019-03-27 2020-10-09 南方医科大学南方医院 一种稀有肿瘤细胞富集方法及试剂盒
JP6886667B2 (ja) * 2019-03-27 2021-06-16 住友ゴム工業株式会社 がん細胞捕捉方法
CN111235021B (zh) * 2020-03-06 2022-09-27 大连海事大学 一种双液相外周血中循环肿瘤细胞分离与检测装置及方法
CN112255408B (zh) * 2020-10-16 2023-04-14 牡丹江医学院 一种肿瘤生物标志物及肿瘤检测试剂盒
CN113117359B (zh) * 2021-03-05 2022-08-26 湘雅生物医药(湖州)有限公司 一种用于胶原蛋白提取用的无菌式蒸馏瓶
CN113049344B (zh) * 2021-04-20 2022-02-01 深圳天烁生物科技有限公司 细胞染色的质控品制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4092246A (en) * 1975-05-16 1978-05-30 Abcor, Inc. Helically wound blood filter
US4829000A (en) * 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US5147797A (en) * 1987-08-25 1992-09-15 Regents Of The University Of Minnesota Polypeptides with fibronectin activity
AU7959494A (en) * 1992-09-11 1996-04-19 Xenogenex, Inc. Artificial liver apparatus and method
FI93742C (fi) * 1992-10-23 1995-05-26 Elias Hakalehto Menetelmä ja laite solujen osoittamiseksi
ATE237676T1 (de) * 1995-02-16 2003-05-15 Forschungszentrum Juelich Gmbh Verfahren zur kultivierung von organfunktionszellen
US5840514A (en) * 1996-11-21 1998-11-24 The Regents Of The University Of Michigan Methods of testing cancer and anticancer drugs
GB9704444D0 (en) * 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
JPH11127843A (ja) * 1997-10-27 1999-05-18 Sumitomo Bakelite Co Ltd 培養用着色容器
US6060317A (en) * 1998-08-11 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Method of transducing mammalian cells, and products related thereto
KR20010075108A (ko) * 1998-09-14 2001-08-09 라즈 외스테르가아드 페데르센 기능적 면역글로불린 수퍼패밀리 단백질을 생산하는 방법
AU2001288437C1 (en) * 2000-09-09 2009-05-21 The Research Foundation Of State University Of New York Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
GB0025245D0 (en) * 2000-10-14 2000-11-29 Lee Helen Multiple target detection
CN1118563C (zh) * 2000-12-08 2003-08-20 中国医学科学院血液学研究所 中空纤维模拟骨髓造血装置
WO2003035888A1 (en) * 2001-08-28 2003-05-01 Wen-Tien Chen Cell separation matrix
ES2284927T3 (es) * 2001-09-06 2007-11-16 Adnagen Ag Procedimiento y kit para el diagnostico o el control del tratamiento del cancer.

Also Published As

Publication number Publication date
HK1209778A1 (zh) 2016-04-08
CN104531529A (zh) 2015-04-22
WO2005043121A2 (en) 2005-05-12
WO2005043121A3 (en) 2006-08-24
EP1706720A2 (en) 2006-10-04
CN1922304A (zh) 2007-02-28
AU2004286307A1 (en) 2005-05-12
EP1706720A4 (en) 2007-02-28
JP2007526761A (ja) 2007-09-20

Similar Documents

Publication Publication Date Title
CA2544373A1 (en) Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
US20050244843A1 (en) Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
DK2542689T3 (en) Method for isolating target cells
US20050272103A1 (en) Cell separation matrix
JP6637484B2 (ja) 血小板を標的とするマイクロ流体細胞単離
Morgan et al. Detection and characterization of circulating and disseminated prostate cancer cells
Ju et al. Detection of circulating tumor cells: opportunities and challenges
US20170234851A1 (en) Methods and Apparatus for Segregation of Particles
Au et al. Clusters of circulating tumor cells: a biophysical and technological perspective
US20130337500A1 (en) System and method for isolation of cells
WO2019214063A1 (zh) 一种循环肿瘤细胞的检测方法
EP1268854A1 (en) High specificity marker detection
JP2008529541A (ja) 腫瘍細胞の分離用容器
WO1996003632A1 (en) Method for preserving cells, and uses of said method
MX2012006244A (es) Metodos y aparatos para segregacion de particulas, incluyendo segregacion y proliferacion de celulas fetales y celulas madre.
Stefansson et al. A cell transportation solution that preserves live circulating tumor cells in patient blood samples
US6998234B2 (en) Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells
JP7306618B2 (ja) がんの転移形成能に関与する因子および前記因子を用いたがん患者の予後予測方法
US20060057650A1 (en) Method for the immunocytological or molecular detection of disseminated tumor cells from a body fluid and kit that is suitable therefor
AU2016395556B2 (en) Method for detecting or separating/obtaining circulating tumor cell employing cell proliferation method
Jiménez‐Zenteno et al. Liquid Biopsy Based on Circulating Cancer‐Associated Cells: Bridging the Gap from an Emerging Concept to a Mainstream Tool in Precision Medicine
WO2003035888A1 (en) Cell separation matrix
Murlidhar Capture and Characterization of Circulating Tumor Cells (CTCs) in Early Lung Cancer Using a Novel High-throughput Affinity-based Microfluidic Device.
CN112946270A (zh) 用于诊断体内恶性实体肿瘤的方法和试剂盒
Harouaka A flexible micro spring array for viable enrichment of circulating tumor cells

Legal Events

Date Code Title Description
FZDE Dead